Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
hsa-mir-378c: Hsa-mir-378c is a miRNA that has been identified as a potential prognostic biomarker for TA treatment in patients with migraine without aura (MWoA) [PMC9871901]. In a study comparing miRNAs in placenta and plasma, it was found that hsa-mir-378c, along with hsa-mir-1246 and hsa-mir-203a-3p, are known to play a role in the pathophysiology of preeclampsia (PE) [PMC9601722]. However, hsa-mir-378e has not been identified as a potential biomarker for PE [PMC9601722]. These findings suggest that hsa-mir-378c may have diagnostic and prognostic value in the treatment of MWoA and could potentially be used as a biomarker for PE. Further research is needed to validate these findings and explore the mechanisms by which hsa-mir-378c contributes to these conditions.
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Localisation
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset